As of 12:30 PM on the 16th, Donggu Bio Pharmaceutical is trading at 23,700 KRW, up 2.82% from the previous day. This represents an 8.47% increase compared to July 1. Donggu Bio Pharmaceutical is known as a pharmaceutical and bio company.
Today, foreign investors are tentatively recorded as net sellers of 14,071 shares. Over the past five days, individual investors have been net buyers of 50,283 shares, while foreign and institutional investors have been net sellers of 37,794 shares and 2,516 shares, respectively.
On July 14, Donggu Bio Pharmaceutical became an issue in the market with the announcement, "Investor company world's first simultaneous Phase 2 clinical trial for Parkinson's and Alzheimer's..."

[Table] Foreign and Institutional Net Trading Volume (Unit: shares)

※ This article was generated in real-time by an article auto-generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
![User Who Sold Erroneously Deposited Bitcoins to Repay Debt and Fund Entertainment... What Did the Supreme Court Decide in 2021? [Legal Issue Check]](https://cwcontent.asiae.co.kr/asiaresize/183/2026020910431234020_1770601391.png)
